Tarsus Pharmaceuticals, Inc. earnings per share and revenue

TARS earnings per share for the last quarter are -0.61 USD whereas the estimation was -0.94 USD which accounts for 35.09% surprise. Company revenue for the same period amounts to 48.12 M USD despite the estimated figure of 43.18 M USD. Estimated earnings per share for the next quarter are -0.77 USD, and revenue is expected to reach 57.53 M USD. Also watch annual changes over time to get a bigger picture of TARS earnings per share and revenue dynamics.